N-Methyl-DL-asparticacid (17833-53-3) Mai ƙera - Cofttek

N-Methyl-DL-asparticacid (17833-53-3)

Yuni 29, 2022

Cofttek shine mafi kyawun masana'anta N-Methyl-DL-asparticacid (17833-53-3) a China. Our factory yana da cikakken samar management tsarin (ISO9001 & ISO14001), tare da wata-wata samar iya aiki na 260kg.


Status: A Mass Production
Naúra: 1kg / jaka, 25kg / Drum

N-Methyl-DL-asparticacid Sfasali

name: N-Methyl-DL-asparticacid
CAS: 17833-53-3
tsarki 98%
Formula kwayoyin: C5H9NO4
Kwayoyin Weight: 147.130 g / mol
Tushewa: 189-190 ºC
Chemical name: (2R)-2-(Methylamino)butanedioic acid
Kamancin: N-Methylaspartate; N-Methyl-D-aspartate; NMDA
InChI Key: HOKKHZGPKSLGJE-GSVOUGTGSA-N
Rabin Rayuwa: N / A
Solubility: Mai narkewa cikin ruwa; Ethanol; DMSO
Yanayin Adana: 0 - 4 C don gajere (kwanaki zuwa makonni), ko -20 C na dogon lokaci (watanni)
Application: N-methyl-D-aspartic acid ko N-methyl-D-aspartate shine asalin amino acid wanda ke aiki a matsayin takamaiman agonist a mai karɓar NMDA yana kwaikwayon aikin glutamate, neurotransmitter wanda yawanci ke aiki a wannan mai karɓar.
Appearance: White foda

 

Menene N-Methyl-DL-asparticacid (17833-53-3)?

N-Methyl-DL-Aspartic Acid (NMDLA) yana wakiltar cakudar launin fata na D da L enantiomers (NMDA; NMLA). Kowane enantiomer yana da ayyuka daban-daban na nazarin halittu da nau'ikan nama/nau'i na halitta daban-daban. Saboda haka, kowane eantiomer ya kamata a yi la'akari daban. NMDA wani neurotoxin ne wanda aka yi nazari sosai wanda shine agonist na mai karɓar NMDA kuma yana haifar da ƙungiyoyin kwakwalwa. Ba a saba samun NMDA a cikin kyallen takarda, yayin da ana iya samun NMLA ta halitta a cikin wasu bivalves.

 

N-Methyl-DL-asparticacid (17833-53-3) fa'idodin

NMDA (N-methyl-D-aspartic acid) sanannen agonist ne ga nau'in masu karɓar glutamate, nau'in NMDA. NMDA na roba yana haifar da aiki mai ƙarfi don ƙaddamar da abubuwan hypothalamic da hypophyseal hormones a cikin dabbobi masu shayarwa. Bugu da ƙari, an samo NMDA na ƙarshe a cikin bera, inda yake da tasiri a cikin ƙaddamar da GnRH (Gonadotropin Releasing Hormone) a cikin hypothalamus, da LH (Luteinizing Hormone) da PRL (Prolactin) a cikin glandar pituitary.

 

N-Methyl-DL-asparticacid (17833-53-3) Aikace-aikace?

N-methyl-d-aspartic acid ko N-methyl-d-aspartate (NMDA) wani nau'in amino acid ne wanda ke aiki a matsayin takamaiman agonist a mai karɓar NMDA yana kwaikwayon aikin glutamate, neurotransmitter wanda yakan yi aiki a wannan mai karɓa. Ba kamar glutamate ba, NMDA yana ɗaure kawai kuma yana daidaita mai karɓar NMDA kuma baya da tasiri akan sauran masu karɓar glutamate (kamar waɗanda na AMPA da kainate). Masu karɓa na NMDA suna da mahimmanci musamman lokacin da suka zama masu wuce gona da iri a lokacin, alal misali, janyewa daga barasa saboda wannan yana haifar da bayyanar cututtuka irin su tashin hankali da, wani lokaci, tashin hankali na epileptiform.

 

N-Methyl-DL-asparticacid foda for sale(Inda za a saya N-Methyl-DL-asparticacid foda a girma)

Kamfaninmu yana jin daɗin haɗin kai tare da abokan cinikinmu saboda mun mai da hankali kan sabis na abokin ciniki da samar da samfuran manyan kayayyaki. Idan kuna da sha'awar samfurinmu, muna jujjuya tare da ƙirƙirar umarni don dacewa da takamaiman buƙatunku da lokacin jagoranmu na sauri akan umarni wanda zai ba ku tabbacin ku ɗanɗano samfurinmu akan lokaci. Hakanan muna mai da hankali kan ayyukan ƙara ƙimar. Muna samuwa don tambayoyin sabis da bayani don tallafawa kasuwancin ku.

Mu masu sana'a ne na N-Methyl-DL-asparticacid foda na shekaru masu yawa, muna ba da samfurori tare da farashi mai gasa, kuma samfurinmu yana da mafi girman inganci kuma yana fuskantar gwaji mai zaman kanta don tabbatar da cewa yana da lafiya don amfani a duniya.

 

References

  1. "N-Methylaspartate - Taƙaitaccen Taro". Cungiyar PubChem. Amurka: Cibiyar Bayar da Bayanan Halitta ta Duniya. 24 Yuni 2005. Ganowa. An dawo da 9 Janairu 2012.
  2. Watkins, JC (Nuwamba 1962). "Hadarin wasu amino acid na acidic da ke da aikin neuropharmacological". Jaridar Magunguna da Magungunan Magunguna. 5 (6): 1187-1199.
  3. Buhari, CV; Oprisan, SA; Buhusi, M (Afrilu 2016). "Agogon cikin agogo: Lokaci ta hanyar gano daidaituwa". Ra'ayi na Yanzu a Kimiyyar Halayyar. 8: 207-213.